Immediate Impact
11 standout
Citing Papers
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation
2023 Standout
Works of L. Unger being referenced
Immune Checkpoint Inhibitor–Related Adverse Effects and18F-FDG PET/CT Findings
2021
Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| L. Unger | 75 | 30 | 42 | 79 | 45 | 23 | 212 | |
| Khader N. Mustafa | 128 | 67 | 34 | 42 | 34 | 19 | 294 | |
| Maria Balabanova | 92 | 22 | 22 | 39 | 41 | 28 | 223 | |
| N. Baudot | 60 | 26 | 62 | 50 | 22 | 29 | 272 | |
| Giovanni Zanframundo | 84 | 42 | 30 | 147 | 76 | 36 | 285 | |
| L. Lojo | 144 | 78 | 18 | 129 | 37 | 32 | 275 | |
| Giorgio Amato | 56 | 78 | 25 | 64 | 25 | 24 | 223 | |
| Arkaitz Mucientes | 81 | 21 | 33 | 19 | 49 | 20 | 278 | |
| Akito Hasegawa | 38 | 25 | 37 | 37 | 26 | 30 | 200 | |
| Maria João Salvador | 26 | 36 | 28 | 29 | 38 | 35 | 243 | |
| Isabelle Amigues | 117 | 48 | 16 | 36 | 47 | 21 | 284 |
All Works
Loading papers...